PMVP Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 22:00):

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer...

Stats
Dagens volum	1.27M
Gjennomsnittsvolum	564 388
Markedsverdi	102.37M
EPS	$0 ( 2024-03-06 )
Neste inntjeningsdato	( $-0.350 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.380
ATR14	$0.00600 (0.30%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-18	Jalota Deepika	Buy	225 095	Employee Stock Option (right to buy)
2024-01-18	Jalota Deepika	Buy	95 555	Common Stock
2024-01-18	Carulli Michael	Buy	204 630	Employee Stock Option (right to buy)
2024-01-18	Carulli Michael	Buy	82 220	Common Stock
2024-01-18	Mack David Henry	Buy	519 915	Employee Stock Option (right to buy)

INSIDER POWER
60.33
Last 97 transactions
Buy: 3 540 873 \| Sell: 1 925 887

Volum Korrelasjon

Lang: 0.48 (neutral)

Kort: -0.85 (strong negative)

Signal:(48.661) Neutral

PMV Pharmaceuticals, Inc. Korrelasjon

10 Mest positive korrelasjoner
FCBC	0.942
HOL	0.938
EVLO	0.937
LGMK	0.935
EQBK	0.935
FIBK	0.935
GRNA	0.933
BHTG	0.931
SLNG	0.928
LYEL	0.928

10 Mest negative korrelasjoner
GVCI	-0.96
APTM	-0.958
SCRM	-0.956
DPCS	-0.956
CCTS	-0.955
ORIA	-0.954
TIOA	-0.954
XPAX	-0.953
ARRW	-0.951
FRONU	-0.951

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

PMV Pharmaceuticals, Inc. Korrelasjon - Valuta/Råvare

0.75
( moderate )

0.74
( moderate )

0.00
( neutral )

0.77
( moderate )

-0.70
( moderate negative )

PMV Pharmaceuticals, Inc. Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$-1.26M (0.00 %)
EPS:	$-1.440

FY	2023
Omsetning:	$0
Bruttogevinst:	$-1.26M (0.00 %)
EPS:	$-1.440

FY	2022
Omsetning:	$0
Bruttogevinst:	$-650 000 (0.00 %)
EPS:	$-1.610

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-1.277

Financial Reports:

No articles found.

PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also developing mutant p53 programs, including Wild-type p53 Induced-Phosphatase, R282W, and R273H, as well as other p53 hotspot mutations. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Cranbury, New Jersey.

Sanntidsoppdatering for PMV Pharmaceuticals, Inc. [PMVP]

Upcoming Earnings Alert